Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1987 Aug;91(4):783–787. doi: 10.1111/j.1476-5381.1987.tb11276.x

Evidence for two different P2-purinoceptors on beta cell and pancreatic vascular bed.

G Bertrand 1, J Chapal 1, M M Loubatières-Mariani 1, M Roye 1
PMCID: PMC1853581  PMID: 3311264

Abstract

1 The effects of a 2-substituted analogue of adenosine 5'-triphosphate (ATP), 2-methylthioadenosine triphosphate (2-methylthio ATP) have been studied on insulin secretion and flow rate of the isolated pancreas of the rat, perfused in the presence of glucose (8.3 mM). 2 2-Methylthio ATP (16.5-1650 nM) increased insulin secretion in a biphasic and concentration-dependent manner; the kinetics were comparable to those previously obtained with ATP. A comparison of relative potency between ATP and 2-methylthio ATP showed that 2-methylthio ATP was 45 times more potent than ATP. 3 2-Methylthio ATP also provoked a transient decrease of the flow rate in a concentration-dependent manner but at concentrations (165-825 microM) about 1000 fold higher than those needed to increase insulin secretion. A comparison of relative potency between the natural derivative and 2-methylthio ATP showed that 2-methylthio ATP was only twice as potent as ATP. 4 These and other previous results (with phosphate-modified analogues of ATP) provide evidence for two different types of P2-purinoceptors on endocrine cell and vessel cells of the pancreas. A P2Y subtype, mediating an increase of insulin secretion, is present on the beta cell of the pancreas. A P2X subtype, mediating vasoconstriction, is present on the vascular bed of the rat pancreas.

Full text

PDF
783

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertrand G., Chapal J., Loubatieres-Mariani M. M. Potentiating synergism between adenosine diphosphate or triphosphate and acetylcholine on insulin secretion. Am J Physiol. 1986 Oct;251(4 Pt 1):E416–E421. doi: 10.1152/ajpendo.1986.251.4.E416. [DOI] [PubMed] [Google Scholar]
  2. Burnstock G., Cusack N. J., Hills J. M., MacKenzie I., Meghji P. Studies on the stereoselectivity of the P2-purinoceptor. Br J Pharmacol. 1983 Aug;79(4):907–913. doi: 10.1111/j.1476-5381.1983.tb10535.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Burnstock G., Cusack N. J., Meldrum L. A. Studies on the stereoselectivity of the P2-purinoceptor on the guinea-pig vas deferens. Br J Pharmacol. 1985 Feb;84(2):431–434. doi: 10.1111/j.1476-5381.1985.tb12927.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen Pharmacol. 1985;16(5):433–440. doi: 10.1016/0306-3623(85)90001-1. [DOI] [PubMed] [Google Scholar]
  5. Chapal J., Loubatieres-Mariani M. M. Attempt to antagonized the stimulatory effect or ATP on insulin secretion. Eur J Pharmacol. 1981 Sep 11;74(2-3):127–134. doi: 10.1016/0014-2999(81)90522-7. [DOI] [PubMed] [Google Scholar]
  6. Chapal J., Loubatieres-Mariani M. M. Evidence for purinergic receptors on vascular smooth muscle in rat pancreas. Eur J Pharmacol. 1983 Mar 4;87(4):423–430. doi: 10.1016/0014-2999(83)90081-x. [DOI] [PubMed] [Google Scholar]
  7. Gordon J. L. Extracellular ATP: effects, sources and fate. Biochem J. 1986 Jan 15;233(2):309–319. doi: 10.1042/bj2330309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gough G. R., Maguire M. H., Satchell D. G. Three new adenosine triphosphate analogs. Synthesis and effects on isolated gut. J Med Chem. 1973 Oct;16(10):1188–1190. doi: 10.1021/jm00268a028. [DOI] [PubMed] [Google Scholar]
  9. HALES C. N., RANDLE P. J. Immunoassay of insulin with insulin-antibody precipitate. Biochem J. 1963 Jul;88:137–146. doi: 10.1042/bj0880137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Kennedy C., Burnstock G. Evidence for two types of P2-purinoceptor in longitudinal muscle of the rabbit portal vein. Eur J Pharmacol. 1985 Apr 23;111(1):49–56. doi: 10.1016/0014-2999(85)90112-8. [DOI] [PubMed] [Google Scholar]
  11. Loubatieres-Mariani M. M., Chapal J., Lignon F., Valette G. Structural specificity of nucleotides for insulin secretory action from the isolated perfused rat pancreas. Eur J Pharmacol. 1979 Nov 16;59(3-4):277–286. doi: 10.1016/0014-2999(79)90291-7. [DOI] [PubMed] [Google Scholar]
  12. Loubatières A., Mariani M. M., Ribes G., de Malbosc H., Chapal J. Etude expérimentale d'un nouveau sulfamide hypoglycémiant particulièrement actif, le HB 419 ou glibenclamide. Diabetologia. 1969 Feb;5(1):1–10. doi: 10.1007/BF01212212. [DOI] [PubMed] [Google Scholar]
  13. Martin W., Cusack N. J., Carleton J. S., Gordon J. L. Specificity of P2-purinoceptor that mediates endothelium-dependent relaxation of the pig aorta. Eur J Pharmacol. 1985 Feb 5;108(3):295–299. doi: 10.1016/0014-2999(85)90452-2. [DOI] [PubMed] [Google Scholar]
  14. Satchell D. G., Maguire M. H. Inhibitory effects of adenine nucleotide analogs on the isolated guinea-pig taenia coli. J Pharmacol Exp Ther. 1975 Dec;195(3):540–548. [PubMed] [Google Scholar]
  15. Soulaymani R., Gross R., Chapal J., Loubatières-Mariani M. M. Effet dilatateur de l'adénosine sur les vaisseaux du pancréas de rat. C R Seances Soc Biol Fil. 1985;179(3):371–374. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES